Yu Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yu Wang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Bi Wang
Guizhou Medical University, Guiyang, Guizhou, China
2 shared publications - Lele Xu
Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China
1 shared publication - Lijie Huang
Department of Neurosurgery, the First Affiliated Hospital OF Wenzhou Medical University, Wenzhou 325000, China
1 shared publication - Qimin Zhan
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing, China
1 shared publication - Shujuan Shao
Liaoning Key Laboratory of Proteomics, Dalian Medical University, Dalian, China
1 shared publication - Tongtong Li
Chinese Academy of Tropical Agricultural Sciences
1 shared publication
Latest Publications
- Open Access
- 18 April 2025
- Published by Association for Computing Machinery (ACM)
- p. 413-419
Research on the Optimization Path of College English Translation Course Based on Smart Teaching Platforms
- 18 April 2025
- Published by Association for Computing Machinery (ACM)
- p. 413-419
Open AccessResearch on the Optimization Path of College English Translation Course Based on Smart Teaching Platforms
- Open Access
- 22 November 2024
- Published by Association for Computing Machinery (ACM)
- p. 346-351
"Empowering Smart Teaching with AIGC in the Ïntegration of Specialization and Innovation\": An Exploration and Practice"
- 22 November 2024
- Published by Association for Computing Machinery (ACM)
- p. 346-351
Open Access"Empowering Smart Teaching with AIGC in the Ïntegration of Specialization and Innovation\": An Exploration and Practice"
- 30 April 2021
- Published by Springer Nature in Oncogene
- Vol. 40 (20) , 3578-3592
Long non-coding RNA SMASR inhibits the EMT by negatively regulating TGF-β/Smad signaling pathway in lung cancer
TGF-β/Smad signaling pathway plays an important role in EMT during cancer progression. Long non-coding RNAs (lncRNAs) are involved in various behaviors of cancer cells, including EMT. Here, we report a novel lncRNA adjacent to Smad3, named Smad3-associated long non-coding RNA (SMASR). SMASR is downregulated by TGF-β via Smad2/3 in lung cancer cells. Knockdown of SMASR induces EMT and increases the migration and invasion of lung cancer cells. Moreover, knockdown of SMASR promotes the phosphorylation of Smad2/3. Mechanistically, SMASR interacts with Smad2/3 and inhibits the expression of TGFBR1, the TGF-β type I receptor responsible for phosphorylation of Smad2/3, thus leading to inactivation of TGF-β/Smad signaling pathway. Clinically, SMASR is downregulated in lung cancer tissues. Collectively, our findings prove a critical role of SMASR in EMT of lung cancer by forming a negative feedback loop with TGF-β/Smad signaling pathway.
- 30 April 2021
- Published by Springer Nature in Oncogene
- Vol. 40 (20) , 3578-3592
Long non-coding RNA SMASR inhibits the EMT by negatively regulating TGF-β/Smad signaling pathway in lung cancer
TGF-β/Smad signaling pathway plays an important role in EMT during cancer progression. Long non-coding RNAs (lncRNAs) are involved in various behaviors of cancer cells, including EMT. Here, we report a novel lncRNA adjacent to Smad3, named Smad3-associated long non-coding RNA (SMASR). SMASR is downregulated by TGF-β via Smad2/3 in lung cancer cells. Knockdown of SMASR induces EMT and increases the migration and invasion of lung cancer cells. Moreover, knockdown of SMASR promotes the phosphorylation of Smad2/3. Mechanistically, SMASR interacts with Smad2/3 and inhibits the expression of TGFBR1, the TGF-β type I receptor responsible for phosphorylation of Smad2/3, thus leading to inactivation of TGF-β/Smad signaling pathway. Clinically, SMASR is downregulated in lung cancer tissues. Collectively, our findings prove a critical role of SMASR in EMT of lung cancer by forming a negative feedback loop with TGF-β/Smad signaling pathway.